These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2503584)

  • 1. Cytokines and pancreatic cancer. Sensitivity of xenotransplants of predominantly pancreatic carcinomas to rIFN-gamma and rTFN-alpha in nude mice.
    Kühl JS; Klapdor R; Bahlo M; Franke N; Kunde C; Arps H; Dietel M
    Int J Pancreatol; 1989 Apr; 4(3):303-19. PubMed ID: 2503584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MAb BW 494/32 and rTNF-a/rIFN-g alone and in combination in nude mice bearing xenografts of human gastrointestinal/pancreatic carcinomas.
    Klapdor R; Schwarzenberg O; Kühl JS; Franke N; Bahlo M
    Strahlenther Onkol; 1989 Jul; 165(7):549-50. PubMed ID: 2501886
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
    Kondo H; Tanaka N; Naomoto Y; Orita K
    Jpn J Cancer Res; 1987 Nov; 78(11):1258-65. PubMed ID: 3121561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of human recombinant interferon-gamma alone and in combination with adriamycin on a human colon cancer cell line (RPMI 4788) in vitro and in nude mice.
    Kondo H; Tanaka N; Orita K
    Jpn J Cancer Res; 1987 Dec; 78(12):1400-8. PubMed ID: 3123441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines and pancreatic cancer. The effect of rIFN-gamma, HuLeIFN, rTNF-alpha, and LAK-cells on pancreatic and other gastrointestinal tumors in vitro.
    Kühl JS; Klapdor R; Mohr H; Arps H; Dietel M
    Int J Pancreatol; 1989 Mar; 4(2):207-19. PubMed ID: 2498436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
    Gridley DS; Slater JM; Stickney DR
    J Biol Response Mod; 1989 Dec; 8(6):593-602. PubMed ID: 2513378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis.
    Benedetto N; Folgore A; Galdiero M; Meli R; Di Carlo R
    Pathol Biol (Paris); 1995 May; 43(5):395-400. PubMed ID: 8532376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy of xenografts of human pancreatic carcinomas with rTNF-alpha and mitomycin C.
    Klapdor R; Franke N; Bahlo M
    Onkologie; 1989 Jun; 12(3):143-7. PubMed ID: 2503798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cytotoxic drugs on tumor marker secretion of gastrointestinal/pancreatic carcinomas--comparison of studies in nude mice and in patients.
    Klapdor U; Klapdor R; Bahlo M; Franke N; Hirschmann M
    Strahlenther Onkol; 1989 Jul; 165(7):550-2. PubMed ID: 2501887
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude mice.
    Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Tun T; Fukumoto M; Tobe T
    Biotherapy; 1991; 3(4):337-44. PubMed ID: 1786197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer.
    Balkwill FR; Ward BG; Moodie E; Fiers W
    Cancer Res; 1987 Sep; 47(18):4755-8. PubMed ID: 3113722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of human breast cancer xenografts in response to intralesional treatment with interferons alpha and gamma potentiated by tumor necrosis factor.
    Ozzello L; de Rosa CM; Cantell K; Kauppinen HL; Habif DV
    J Interferon Cytokine Res; 1995 Oct; 15(10):839-48. PubMed ID: 8564705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor effects of recombinant human leukocyte interferon (rIFN-alpha A) on human malignomas transplanted into nude mice].
    Hashizume S
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):284-8. PubMed ID: 3970552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined effect of human recombinant interferon-beta and interferon-gamma against an experimental model of peritonitis carcinomatosa in nude mice].
    Kondo H; Tanaka N; Naomoto Y; Orita K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1836-40. PubMed ID: 3109328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats.
    Debs RJ; Fuchs HJ; Philip R; Montgomery AB; Brunette EN; Liggitt D; Patton JS; Shellito JE
    J Immunol; 1988 May; 140(10):3482-8. PubMed ID: 3283235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytes.
    Weiner LM; Steplewski Z; Koprowski H; Litwin S; Comis RL
    Cancer Res; 1988 Feb; 48(4):1042-6. PubMed ID: 3123051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
    Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
    Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    Bermudez LE; Young LS
    J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
    Heston WD; Fleischmann J; Tackett RE; Ratliff TL
    Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.